Browse Studies — Arctuva

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spr…

BPH (Benign Prostatic Hyperplasia)

Estimated

~$10 – $1,050

Zenflow, Inc.NCT07538622

Observational

PuraStat for Aquablation Day Case (Use of PuraStat Following an Aquablation Procedure)

Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

BPH (Benign Prostatic Hyperplasia)BPH With Symptomatic Lower Urinary Tract Symptoms

Estimated

~$10 – $7,500

Endeavor HealthNCT07789041

SONAFUSION Registry (Long-term Evaluation of Sonablate High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer and Benign Prostatic Hyperplasia)

The SONA FUSION Registry is an observational study designed to evaluate the long-term effectiveness and safety of the Sonablate High-Intensity Focused Ultrasou…

Localized Prostate CancerBPH (Benign Prostatic Hyperplasia)Prostate Cancer; Benign Prostatic Hyperplasia

Estimated

~$10 – $1,125

SonablateNCT07757490

Phase 2

A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)

SRD5A2 is a critical enzyme for prostatic development and growth, and the SRD5A2 inhibitor, finasteride, is used to treat benign prostatic hyperplasia (BPH). S…

BPH (Benign Prostatic Hyperplasia)Lower Urinary Track Symptoms

Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT06944145